{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:52:47Z","timestamp":1793749967803,"version":"4.6.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.metabol.2014.05.012","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T13:02:51Z","timestamp":1402491771000},"page":"1217-1227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["\u03b2-Cell function in type 2 diabetes"],"prefix":"10.1016","volume":"63","author":[{"given":"Ele","family":"Ferrannini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.metabol.2014.05.012_bb0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","article-title":"Pancreatic \u03b2-cell mass in European subjects with type 2 diabetes","volume":"10","author":"Rahier","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4161\/isl.24780","article-title":"Small human islets comprised of more \u03b2-cells with higher insulin content than large islets","volume":"5","author":"Farhat","year":"2013","journal-title":"Islets"},{"key":"10.1016\/j.metabol.2014.05.012_bb0015","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/me.2013-1278","article-title":"Minireview: intraislet regulation of insulin secretion in humans","volume":"27","author":"Rut0074er","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2014.05.012_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/000456329903600407","article-title":"Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link?","volume":"36","author":"Morgan","year":"1999","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.metabol.2014.05.012_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.19.4.0336","article-title":"Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects","volume":"19","author":"Ferrannini","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2014.05.012_bb0030","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1210\/jc.2007-0334","article-title":"Insulin resistance, insulin response, and obesity as indicators of metabolic risk","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0035","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.2337\/diabetes.54.8.2382","article-title":"beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss","volume":"54","author":"Camastra","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/diacare.15.3.318","article-title":"Pathogenesis of MIDDM. A balanced overview","volume":"15","author":"DeFronzo","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1463-1326.1999.00017.x","article-title":"Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin-secreting cell lines","volume":"1","author":"McClenaghan","year":"1999","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00125-003-1169-6","article-title":"Predominant role of reduced b-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance","volume":"46","author":"Ferrannini","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0060","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2337\/diab.45.2.242","article-title":"Report of the American Diabetes Association's Task Force on standardization of the insulin assay","volume":"45","author":"Robbins","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/dmr.5610030201","article-title":"The kinetics of insulin in man. I. General aspects","volume":"3","author":"Ferrannini","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.metabol.2014.05.012_bb0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.metabol.2011.08.001","article-title":"Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models","volume":"61","author":"Tura","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2014.05.012_bb0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI109445","article-title":"Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance","volume":"64","author":"Ferrannini","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0080","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1210\/jcem-51-3-520","article-title":"Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior","volume":"51","author":"Eaton","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0090","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2362.1999.00536.x","article-title":"Insulin: new roles for an ancient hormone","volume":"29","author":"Ferrannini","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0095","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0100","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI110398","article-title":"Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose","volume":"68","author":"Bergman","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2014.05.012_bb0110","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2337\/diabetes.51.2007.S130","article-title":"Effect of acute hyperglycemia on insulin secretion in man","volume":"51","author":"Toschi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2337\/diab.32.1.35","article-title":"Regulation of Splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man","volume":"32","author":"DeFronzo","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0120","first-page":"E21","article-title":"Insulin secretion and clearance during low-dose graded glucose infusion","volume":"268","author":"Byrne","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2014.05.012_bb0125","first-page":"E2","article-title":"Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models","volume":"280","author":"Toffolo","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2014.05.012_bb0130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI111542","article-title":"Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus","volume":"74","author":"Ward","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0135","series-title":"Diabetes Mellitus","first-page":"47","article-title":"Electrophysiology of the pancreatic \u03b2-cell","author":"Mears","year":"2000"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2014.05.012_bb0140","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.2337\/diabetes.51.2007.S60","article-title":"Signals and pools underlying biphasic insulin secretion","volume":"51","author":"Henquin","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0145","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1210\/jc.2002-021479","article-title":"Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans","volume":"88","author":"Vahl","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0150","first-page":"E57","article-title":"Effects of acute alpha 2-blockade on insulin action and secretion in humans","volume":"274","author":"Natali","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2014.05.012_bb0155","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1464-5491.2008.02441.x","article-title":"Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes","volume":"25","author":"Mari","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2014.05.012_bb0165","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1002\/dme.1996.13.s6.40","article-title":"Natural history of impaired glucose tolerance: follow-up at Joslin Clinic","volume":"13","author":"Warram","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2014.05.012_bb0170","first-page":"583","article-title":"The pilot gland approach to the study of insulin secretory dynamics","volume":"27","author":"Bergman","year":"1971","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.metabol.2014.05.012_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0092-8240(73)80007-2","article-title":"Threshold secretory mechanism: a model of derivative element in biological control","volume":"35","author":"Licko","year":"1973","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.metabol.2014.05.012_bb0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2362.1974.tb00403.x","article-title":"A mathematical model for the glucose induced insulin release in man","volume":"4","author":"Cerasi","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2337\/diab.29.12.979","article-title":"Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog","volume":"29","author":"Toffolo","year":"1980","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.50.1.150","article-title":"Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity","volume":"50","author":"Breda","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2362.2001.00827.x","article-title":"Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion","volume":"31","author":"Cretti","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0200","first-page":"E1159","article-title":"Meal and oral glucose tests for the assessment of \u03b2-cell function: modeling analysis in normal subjects","author":"Mari","year":"2002","journal-title":"Am J Physiol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2014.05.012_bb0205","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","article-title":"Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation","volume":"51","author":"Mari","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0210","first-page":"495","article-title":"Mathematical modeling in glucose metabolism and insulin secretion","volume":"5","author":"Mari","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0215","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI107011","article-title":"A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling","volume":"51","author":"Grodsky","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0220","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.2337\/db13-0321","article-title":"Long-term effects of bariatric surgery on meal disposal and \u03b2-cell function in diabetic and nondiabetic patients","volume":"62","author":"Camastra","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0225","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/endo-121-3-1017","article-title":"Biphasic insulin release as the expression of combined inhibitory and potentiating effects of glucose","volume":"121","author":"Nesher","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2014.05.012_bb0230","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0235","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/dme.1996.13.s6.25","article-title":"Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus","volume":"13","author":"Porte","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2014.05.012_bb0240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0245","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/db13-1198","article-title":"The oral minimal model method","volume":"63","author":"Cobelli","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0250","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00125-004-1381-z","article-title":"Beta cell function and its relation to insulin action in humans: a critical appraisal","volume":"47","author":"Ferrannini","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0255","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0265","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2004-1133","article-title":"beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis","volume":"90","author":"Ferrannini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0270","first-page":"749","article-title":"The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives","volume":"53","author":"Hills","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0275","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00125-009-1647-6","article-title":"Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance","volume":"53","author":"Mari","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0280","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1007\/s00125-005-0004-7","article-title":"Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects","volume":"48","author":"Walker","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0285","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00125-011-2112-x","article-title":"Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study","volume":"54","author":"Ferrannini","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0290","doi-asserted-by":"crossref","first-page":"e50419","DOI":"10.1371\/journal.pone.0050419","article-title":"Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters","volume":"7","author":"Tura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2014.05.012_bb0295","doi-asserted-by":"crossref","first-page":"E1590","DOI":"10.1152\/ajpendo.00669.2006","article-title":"Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia","volume":"292","author":"Kim","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI10761","article-title":"Interactions between insulin resistance and insulin secretion in the development of glucose intolerance","volume":"106","author":"Cavanagh","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0310","doi-asserted-by":"crossref","first-page":"10--18","DOI":"10.1007\/s00125-010-1896-4","article-title":"Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?","volume":"54","author":"Nauck","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0315","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/jc.2013-3994","article-title":"GIP contributes to islet tri-hormonal abnormalities in type 2 diabetes","volume":"99","author":"Chia","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0320","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2337\/db11-0827","article-title":"Influence of hyperinsulinemia and insulin resistance on in vivo \u03b2-cell function: their role in human \u03b2-cell dysfunction","volume":"60","author":"Mari","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0325","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0330","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/db08-1611","article-title":"Functional assessment of pancreatic beta-cell area in humans","volume":"58","author":"Meier","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0340","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0345","doi-asserted-by":"crossref","first-page":"1340-138","DOI":"10.2337\/db10-1119","article-title":"Diabetes Prevention Program Research Group. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program","volume":"60","author":"Hivert","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc11-2106","article-title":"Predicting Diabetes: Our relentless quest for genomic nuggets","volume":"35","author":"Dagogo-Jack","year":"2012","journal-title":"Diabetes Care"},{"issue":"9922","key":"10.1016\/j.metabol.2014.05.012_bb0355","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"Tuomi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.05.012_bb0360","first-page":"1462","article-title":"Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons","volume":"151","author":"Guardado-Mendoza","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2014.05.012_bb0365","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/en.2009-1277","article-title":"\u03b2-cell mass dynamics and islet cell plasticity in human type 2 diabetes","volume":"151","author":"Hanley","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2014.05.012_bb0370","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1210\/jc.2004-0150","article-title":"Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin","volume":"89","author":"Marchetti","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0375","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1210\/jc.2007-2260","article-title":"Incretin hypersecretion in post-gastric bypass hypoglycemia\u2013primary problem or red herring?","volume":"92","author":"Vella","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/dc11-1272","article-title":"Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study","volume":"35","author":"de Mello","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0385","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/db10-1392","article-title":"The ADOPT study group. Effects of rosiglitazone, glyburide, and metformin on b-cell function and insulin sensitivity in ADOPT","volume":"60","author":"Kahn","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0390","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2337\/diacare.28.5.1132","article-title":"Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide","volume":"28","author":"Mari","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0395","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1055\/s-2006-956505","article-title":"Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea","volume":"38","author":"Mari","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2014.05.012_bb0400","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1210\/jc.2012-1205","article-title":"Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes","volume":"97","author":"Muscelli","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0405","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0410","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.05.012_bb0415","first-page":"2765","article-title":"The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery","volume":"98","author":"Nannipieri","year":"2013","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.metabol.2014.05.012_bb0420","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1210\/jc.2013-1476","article-title":"Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms","volume":"98","author":"Astiarraga","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0425","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2337\/dc11-0291","article-title":"Effects of exenatide on measures of \u03b2-cell function after 3years in metformin-treated patients with type 2 diabetes","volume":"34","author":"Bunck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0430","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00125-011-2167-8","article-title":"Beta cell function following 1year vildagliptin or placebo treatment and after 12week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial","volume":"54","author":"Foley","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0435","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0440","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1172\/JCI119562","article-title":"Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance","volume":"100","author":"Cavaghan","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2014.05.012_bb0445","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0450","doi-asserted-by":"crossref","first-page":"E871","DOI":"10.1152\/ajpendo.00551.2006","article-title":"Thiazolidinediones improve beta-cell function in type 2 diabetic patients","volume":"292","author":"Gastaldelli","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0455","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s001250051508","article-title":"Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells","volume":"43","author":"Dubois","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2014.05.012_bb0460","doi-asserted-by":"crossref","first-page":"E560","DOI":"10.1152\/ajpendo.00561.2002","article-title":"Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR\u03b32 in the modulation of insulin secretion","volume":"286","author":"Lupi","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0465","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1074\/jbc.273.6.3547","article-title":"Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats","volume":"273","author":"Shimabukuro","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2014.05.012_bb0470","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2337\/db13-1455","article-title":"Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes (T2D) utilizing DPP-4 inhibition and GLP-1-receptor blockade","volume":"63","author":"Aulinger","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0475","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/db13-0805","article-title":"Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and \u201cisoglycemic\u201d intravenous glucose","volume":"63","author":"Vardarli","year":"2014","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2014.05.012_bb0480","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.2337\/dc11-s227","article-title":"Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes","volume":"34","author":"Holst","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.05.012_bb0485","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db13-0617","article-title":"The \u03b2-cell\/EC axis: how do islet cells talk to each other?","volume":"63","author":"Peiris","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0490","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/db13-1013","article-title":"Insulin resistance alters islet morphology in non-diabetic humans","volume":"63","author":"Mezza","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2014.05.012_bb0495","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2010.04.009","article-title":"The stunned beta cell: a brief history","volume":"11","author":"Ferrannini","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2014.05.012_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-014-3219-7","article-title":"Altered pattern of the incretin effect as assessed by modelling in subjects spanning from normal to diabetic glucose tolerance","author":"Tura","year":"2014","journal-title":"Diabetologia"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:04:01Z","timestamp":1758427441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0026049514001619"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.05.012","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Cell function in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}